Press Release Excerpt
We are pleased to announce that Brookwood Associates advised PMG Research, Inc. ("PMG"), a leading provider of clinical trial management services for the pharmaceutical industry, in its sale to Inclinix, Inc., a portfolio company of Frontier Capital. Serving large pharmaceutical, biotech and contract research organizations, PMG's 10 research sites manage clinical studies for new drug development across a wide range of therapeutic areas, including endocrinology, neurology, cardiology, dermatology and infectious disease. The combined entity offers drug developers and clinical research organizations an exceptional network of 120 principal investigators, 80 study coordinators and more than 75 global enrollment managers. The transaction also provides PMG with a valuable new partner to support and facilitate growth while allowing its selling shareholders to realize an attractive outcome.
The sale of PMG extends Brookwood's track record in advising outsourced service providers to the healthcare and pharmaceutical sectors, and represents Brookwood's seventh business services transaction in the past 12 months. Brookwood's industry knowledge and skillful process management were instrumental in creating meaningful strategic interest and navigating an ownership transition that ultimately generated a successful outcome for all shareholders.